Quantum BioPharma Ltd. (QNTM)
NASDAQ: QNTM · Real-Time Price · USD
3.230
+0.330 (11.38%)
At close: Aug 6, 2026, 4:00 PM EDT
3.200
-0.030 (-0.93%)
Pre-market: Aug 7, 2026, 7:39 AM EDT
Quantum BioPharma Market Cap
Quantum BioPharma has a market cap or net worth of $20.06 million as of August 7, 2026. Its market cap has decreased by -69.88% in one year.
Market Cap
20.06M
Enterprise Value
14.38M
1-Year Change
-69.88%
Ranking
Category
Stock Price
$3.23
ChartMarket Cap Chart
Since January 9, 2020, Quantum BioPharma's market cap has decreased from $53.50M to $20.06M, a decrease of -62.50%. That is a compound annual growth rate of -13.85%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2026 | 12.60M | -54.84% |
| Dec 31, 2025 | 27.90M | 304.35% |
| Dec 31, 2024 | 6.90M | -80.94% |
| Dec 29, 2023 | 36.20M | 20.67% |
| Dec 30, 2022 | 30.00M | -27.18% |
| Dec 31, 2021 | 41.20M | 108.08% |
| Dec 31, 2020 | 19.80M | -62.99% |
| Jan 9, 2020 | 53.50M | - |
View and export this data all the way back to 2020. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Polyrizon | 19.09M |
| Tvardi Therapeutics | 19.04M |
| Jasper Therapeutics | 18.63M |
| NewcelX | 18.57M |
| NeuroSense Therapeutics | 18.38M |
| GridAI Technologies | 18.30M |
| Lipocine | 17.56M |
| Citius Pharmaceuticals | 17.09M |